Assetmark Inc. Has $7.81 Million Holdings in Ventas, Inc. $VTR

Assetmark Inc. increased its holdings in Ventas, Inc. (NYSE:VTR) by 8.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 100,956 shares of the real estate investment trust’s stock after acquiring an additional 7,949 shares during the period. Assetmark Inc.’s holdings in Ventas were worth $7,812,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Transcend Capital Advisors LLC boosted its holdings in Ventas by 46.5% in the 4th quarter. Transcend Capital Advisors LLC now owns 4,263 shares of the real estate investment trust’s stock worth $330,000 after buying an additional 1,354 shares during the period. State of Alaska Department of Revenue lifted its holdings in shares of Ventas by 2.9% during the fourth quarter. State of Alaska Department of Revenue now owns 278,447 shares of the real estate investment trust’s stock valued at $21,544,000 after purchasing an additional 7,830 shares during the last quarter. Bayhunt Capital LLC bought a new position in Ventas in the 4th quarter worth about $12,489,000. Howard Capital Management Inc. bought a new position in Ventas in the 4th quarter worth about $210,000. Finally, Apollon Wealth Management LLC raised its position in Ventas by 90.5% in the 4th quarter. Apollon Wealth Management LLC now owns 7,200 shares of the real estate investment trust’s stock worth $557,000 after buying an additional 3,420 shares during the last quarter. 94.18% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

VTR has been the subject of several analyst reports. Royal Bank Of Canada increased their target price on shares of Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a report on Tuesday, February 10th. Wells Fargo & Company increased their target price on Ventas from $88.00 to $93.00 and gave the stock an “overweight” rating in a research note on Thursday, March 26th. UBS Group restated a “neutral” rating and set a $85.00 price target on shares of Ventas in a research note on Monday, February 9th. Citigroup lifted their target price on Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. Finally, JPMorgan Chase & Co. lifted their price target on Ventas from $88.00 to $93.00 and gave the company an “overweight” rating in a research report on Friday, March 20th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $90.47.

Insider Activity at Ventas

In other news, CEO Debra A. Cafaro sold 10,322 shares of the company’s stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the transaction, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Carey S. Roberts sold 35,532 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at $6,184,175. This represents a 32.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.53% of the stock is currently owned by corporate insiders.

Ventas Trading Down 0.5%

VTR opened at $85.12 on Friday. The company has a market cap of $40.47 billion, a P/E ratio of 157.64, a PEG ratio of 2.11 and a beta of 0.75. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67. Ventas, Inc. has a one year low of $61.76 and a one year high of $88.36. The business’s 50-day simple moving average is $84.88 and its 200-day simple moving average is $79.06.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The company had revenue of ($1,229.71) million for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the business posted $0.81 earnings per share. The firm’s revenue was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, equities research analysts expect that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, April 16th. Investors of record on Tuesday, March 31st were issued a $0.52 dividend. This is an increase from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Tuesday, March 31st. Ventas’s dividend payout ratio is presently 385.19%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.